Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.

Marignani M, Mangone M, Cox MC, Angeletti S, Veggia B, Ferrari A, di Fonzo M, Begini P, Gigante E, Laverde G, Aloe-Spiriti A, Monarca B, Delle Fave G.

Dig Liver Dis. 2011 Feb;43(2):139-42. doi: 10.1016/j.dld.2010.05.010. Epub 2010 Jun 15.

PMID:
20554488
2.

Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.

Nosotti L, D'Andrea M, Pitidis A, Pimpinelli F, Dessanti ML, Pisani F, Vignally P, Petti MC.

Scand J Infect Dis. 2012 Jan;44(1):70-3. doi: 10.3109/00365548.2011.611819. Epub 2011 Sep 12.

PMID:
21905952
3.

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.

Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J, Kusumoto S, Okamoto M, Yokoyama M, Takamatsu Y, Sunami K, Miyata A, Murayama K, Sakai A, Matsumoto M, Shinagawa K, Takaki A, Matsuo K, Kinoshita T, Tanimoto M.

Blood. 2010 Dec 9;116(24):5119-25. doi: 10.1182/blood-2010-06-289231. Epub 2010 Sep 7.

4.

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.

Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Okamoto H, Tanimoto M, Hatake K.

Am J Hematol. 2008 Jan;83(1):59-62.

5.

Hepatitis C virus infection in non-Hodgkin's lymphoma.

King PD, Wilkes JD, Diaz-Arias AA.

Clin Lab Haematol. 1998 Apr;20(2):107-10.

PMID:
9681221
6.

Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.

Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K.

Intern Med. 2000 Feb;39(2):112-7. Review.

7.

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.

Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, Reyes F, Hermine O; Groupe d'Etude des Lymphomes de l'Adulte Programs.

J Clin Oncol. 2006 Feb 20;24(6):953-60. Epub 2006 Jan 17.

PMID:
16418500
8.

Role of ribavirin in hepatitis flare in HCV-infected patients with B cell non Hodgkin's lymphoma treated with rituximab-containing regimens.

Pellicelli AM, Zoli V.

Dig Liver Dis. 2011 Jun;43(6):501-2. doi: 10.1016/j.dld.2010.12.018. Epub 2011 Apr 1. No abstract available.

PMID:
21459059
9.

HCV and HGV in B-cell non-Hodgkin's lymphoma.

Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prümmer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K.

J Hepatol. 1998 Jan;28(1):34-9.

PMID:
9537861
10.

Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.

Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM.

J Med Virol. 2002 Aug;67(4):510-5.

PMID:
12115996
11.

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, et al.

Br J Haematol. 1994 Oct;88(2):392-4.

PMID:
7803287
12.

[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].

Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):486-9. Chinese.

PMID:
16613686
13.

[Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma].

Gasztonyi B, Pár A, Szomor A, Nagy A, Kereskai L, Losonczy H, Pajor L, Horanyi M, Mózsik G.

Orv Hetil. 2000 Dec 3;141(49):2649-51. Hungarian.

PMID:
11138474
14.

Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.

Zucca E, Roggero E, Maggi-Solcà N, Conconi A, Bertoni F, Reilly I, Castelli D, Pedrinis E, Piffaretti JC, Cavalli F.

Haematologica. 2000 Feb;85(2):147-53.

15.

Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.

Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght B, Morais JC, Milito C, Moraes Coelho HS.

Oncol Rep. 2002 May-Jun;9(3):657-9.

PMID:
11956646
16.

Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.

Sève P, Renaudier P, Sasco AJ, Dumontet C, Salles G, Coiffier B, Zoulim F, Broussolle C, Trépo C.

Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1361-5.

PMID:
15618846
17.

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.

Mohamedbhai SG, Sibson K, Marafioti T, Kayani I, Lowry L, Goldstone AH, Linch DC, Ardeshna KM.

Br J Haematol. 2011 Jan;152(2):175-81. doi: 10.1111/j.1365-2141.2010.08447.x. Epub 2010 Nov 24.

PMID:
21092025
18.

Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K.

J Gastroenterol Hepatol. 2001 Feb;16(2):215-9.

PMID:
11207904
19.

Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.

Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Specchia G, Montanaro M, Barbui AM, Nieddu R, Pagano L, Rapicetta M, Franceschi S, Mandelli F, Pulsoni A; Italian Multi-Center case-control study.

Haematologica. 2004 Jan;89(1):70-6.

20.

Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.

Tobinai K, Ogura M, Itoh K, Kinoshita T, Hotta T, Watanabe T, Morishima Y, Igarashi T, Terauchi T, Ohashi Y; All Collaborators of the IDEC-C2B8 Study Group in Japan.

Cancer Sci. 2010 Dec;101(12):2579-85. doi: 10.1111/j.1349-7006.2010.01703.x.

Supplemental Content

Support Center